Doxecitine and doxribtimine (KYGEVVI™)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Publication (if available)
Thymidine Kinase 2 (TK2) deficiency An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency Phase 2 TK0102
Ongoing 		NCT03845712
2018-004277-27
2023-510427-29-00		 Garone, C. et al. European Journal of Human Genetics 2025; 33 (suppl 1), 704–706. European Society of Human Genetics - 2025 Conference (ESHG), May 24-27, 2025; Milan, Italy